The availability of targeted therapies is beginning to allow for personalized treatment in advanced prostate cancer. Several abstracts related to m......READ MORE
Predictive biomarkers promise to optimize the patient selection for tailored therapy. Several abstracts at the 2021 Genitourinary Cancers Symposium......READ MORE
As seen at the 2021 Genitourinary Cancers Symposium, targeted radionuclide therapy and other precision and immune-based treatments promise to deliv......READ MORE
Strategies to sequence and combine therapies for patients with advanced prostate cancer continue to evolve as newer treatments emerge and data from......READ MORE
Advancements in imaging and the identification of clinical and genomic risk factors are improving the treatment of patients with high-risk localize......READ MORE
Prostate-specific membrane antigen (PSMA) has emerged as a preeminent prostate cancer target for diagnostic imaging. Additionally, as seen at the 2......READ MORE
